FilingIndex
8-KThe WireRoutine

Reg FD Disclosure · Company Update

Filed Jun 12, 2026 · 21d ago · Accession 0001193125-26-269734

Plain English

The Company announced that the acquisition of XOMA Royalty Holdings Corporation by Ligand Pharmaceuticals Incorporated is expected to close on or about July 14, 2026, and that it has initiated the redemption of all outstanding Series A and Series B Preferred Stock on July 14, 2026.

Read the original on SEC.gov ↗
Filing details
Ticker
XOMA
CIK
791908
Form type
8-K
Filing date
Jun 12, 2026
Report date
Jun 12, 2026
Document
d143305d8k.htm
Size
223 KB